Kabarak University's School of Medicine and Health Sciences is conducting a performance evaluation project on the Liaison QuantiFERON-TB GOLD Plus manufactured by Diasorin S.P.A and QUIAGEN. This project is aimed at assessing the accuracy and effectiveness of the Liaison QuantiFERON-TB GOLD Plus in diagnosing latent tuberculosis. To carry out this project, the team received training from Mr. David Waweru and Ms. Esther Wambui from Surgipath services EA LTD, the local partners and experts in this field.
The Liaison QuantiFERON-TB GOLD Plus is a cutting-edge test that detects tuberculosis infection by measuring the release of interferon-gamma in response to specific TB antigens. This innovative test is more reliable and accurate than traditional methods currently in use, making it a game-changer in the field of TB diagnosis.
Leading the charge on this exciting project are Dr. Josephat Tonui and Dr. Michael Walekhwa, renowned scientists in the Department of Biomedical Sciences, under the leadership of the esteemed Dean of the School of Medicine & Health Sciences, Dr. Pamela Kimetto. Their primary objective is to evaluate the performance of the Liaison QuantiFERON-TB GOLD Plus in a clinical setting to determine its diagnostic accuracy and feasibility.
Thanks to the comprehensive training provided by Surgipath, the team is well-equipped with the necessary knowledge and skills to conduct the project effectively. They have learned about the different stages involved in the performance evaluation process, including sample collection, preparation, and analysis, as well as quality control and assurance procedures to ensure accurate and reliable results.
The results of this project will provide valuable insights into the diagnostic accuracy and feasibility of the Liaison QuantiFERON-TB GOLD Plus in a clinical setting. This will help healthcare professionals make more informed decisions when diagnosing latent tuberculosis and managing patient care. Additionally, the project aims to contribute to the body of knowledge on TB diagnosis and management, which will have a significant impact on public health policies and practices.
Overall, the performance evaluation project of the Liaison QuantiFERON-TB GOLD Plus is an exciting initiative that will benefit patients, healthcare providers, and researchers alike. With the expertise of the team and the training provided by Surgipath, the project is sure to be conducted with the highest level of professionalism and quality. This project highlights the importance of research and training in advancing the field of medicine and improving patient care.